# WHO approves trials for two new Ebola vaccines

> **Newsylist Open Intelligence Dossier** · First detected: 2026-11-05 01:29 UTC · Category: Health · Sources: 5 · Current Velocity: 2.8

## Intelligence Brief
"WHO approves trials for two new Ebola vaccines" developed substantial multi-source reporting across the Health sector, tracked across 5 distinct newsrooms by Newsylist.


Key reporting was led by The Independent, ReliefWeb, Seeking Alpha and World Health Organization (WHO). Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for WHO approves trials for two new Ebola vaccines?
Coverage spiked when 5 independent newsrooms published 5 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| The Independent | The treatments being developed for the Bundibugyo strain of Ebola | 2026-11-04 19:43 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxNUHdRYV85dkpvOUNBVWl2WjVnYzlLNjA2ZnVabTMwM1oyYkg5cHFJQ1hMdWhpdFUtM1kwUEZMNDFhS2dRZzdnVVdQZWhkYUlXUEpJMHFJczBDYUlkOVNCS3phbHBCcUExQnR5MFNrNFJuRm1lRkVoSkZRUzBKclhjY0ZOQ09HQmR5Z254SHo1OXNkWnhT?oc=5) |
| ReliefWeb | Vaccines for the 2026 Bundibugyo Ebola disease outbreak: access gaps and recommendations | 2026-11-04 19:43 | [Source Link](https://news.google.com/rss/articles/CBMizwFBVV95cUxQZ1FvLVdrTThISzNGUVIwemktUS1VbV9lelBtaEZ6WnlQVnh5cmxNcFhqMlFkRHN6MTNfNFFxMFFCbmhjSzh3bW9CLXhlZjJBRG9VWVFJVmxVbHl6SXo2UFoycmQ0NUxBMHU0eHdjR3dyeDNkN3JlakJHWVBXNjJaTUhxekdIRFplSE9NbUw3eEd6cC1kaXBEYzN6ZzRMSlF3REh2Y182NHQzcGdYUnp4eGZIU0w3THpUMzV6ZXhlSmd0Z0d2R1hCMkhvQl95OFk?oc=5) |
| Seeking Alpha | Moderna Ebola vaccine picked for Phase 2/3 trial (MRNA:NASDAQ) | 2026-11-04 19:43 | [Source Link](https://news.google.com/rss/articles/CBMiiAFBVV95cUxQdVlzN2xzUW5DVnBqREpKVVZ0UGJlbHRXTEZ0T3dUUW1TUk9HUHV4UC0yOUwzaFlmdjZZNkVKVlZnVTBnWTdlMVh5bmJYOGtONk5nUVpXaUIwOWFZQkdqWi1yLWdRUWo3NEdfcmltVEJQZ1pZcURhcG9qTktMZXAtb21sVUpfd3At?oc=5) |
| World Health Organization (WHO) | Two new candidate vaccines to join Ebola trial as treatment research advances | 2026-11-04 19:43 | [Source Link](https://news.google.com/rss/articles/CBMiugFBVV95cUxNajgxMmhDVFhROUE5Y0F0cmI2MWFCUkRIOUVwUFJpOVFfYXg4UTU0QTNYNGhpeEtvUjZESFhaYlBUUVpzaWNVYXFNeThoNUI0WXhWLUREbFFqLWZWZUxiNUNsWXp4eEZwa3FxdHU1b1VrWi1yQnpJSWtfY1BSMF9aZEkxbU8tRWJBdWVydGdrNFpiNmN0MldHV0ZDSVJmR1Z5blBCWEx1N2VnUURCdFRfek80VVp6SDVRSkE?oc=5) |
| Al Jazeera | WHO approves trials for two new Ebola vaccines | 2026-11-04 19:43 | [Source Link](https://news.google.com/rss/articles/CBMikAFBVV95cUxQTEc3VWRicmFISXlSQWxkVWhYYWM1ZTBfNk9HMVpNaFV3dlpveDFfRWNFWHBTT1Z5TW1pUF8tLU9OUkNaNmFnMUZ0ajFQaEZjTUpsY21KemJzRlBhTjdGWFlSbEU4QURwMEFFMUVkNlZrM2NtOVNZV0FRV0xlWm4zeXFqbXZoZENiRk9ITlVzNm_SAZYBQVVfeXFMT3QzSDNZNGhnSU5WVG1pdDc4OU42YXNoWGhRYm9Mc1NlcG5ENkttMlBCMnE3UURaaGxqREhxai1lMk5XbVlWRUZYM2MtdS1lUDhTSXJLVW9lUEpnYTZWd0RUUWZDODc0TEw4NEtheE9vMGx1SmNBVG1TTlpLaFctUzBKQ25wemY0NnlmdFNHb2JKWjQ3eVVn?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-11-05/who-approves-trials-for-two-new-ebola-vaccines*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*